Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 09, 2023

SELL
$2.48 - $3.43 $67,418 - $93,244
-27,185 Reduced 39.05%
42,427 $0
Q3 2022

Nov 04, 2022

BUY
$3.14 - $6.43 $6,264 - $12,827
1,995 Added 2.95%
69,612 $226,000
Q2 2022

Aug 01, 2022

SELL
$4.74 - $8.15 $32,587 - $56,031
-6,875 Reduced 9.23%
67,617 $330,000
Q1 2022

May 12, 2022

BUY
$6.47 - $9.57 $16,142 - $23,877
2,495 Added 3.47%
74,492 $568,000
Q4 2021

Jan 31, 2022

BUY
$9.02 - $13.5 $649,412 - $971,959
71,997 New
71,997 $665,000

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $406M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.